# Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

> **NCT00633698** · PHASE3 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 150 (estimated)

## Conditions studied

- Elevated Lipoprotein(a) Levels

## Interventions

- **DRUG:** Nicotinic acid (niacin)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00633698
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633698, "Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00633698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*